EBOS GROUP LIMITED (EBO)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

EBO - EBOS GROUP LIMITED

FNArena Sector : Healthcare services
Year End: June
GICS Industry Group : Health Care Equipment & Services
Index: ALL-ORDS

LAST PRICE CHANGE +/- CHANGE % VOLUME

$33.99

26 Oct
2021

0.090

OPEN

$33.90

0.27%

HIGH

$34.41

8,767

LOW

$33.83

TARGET
$32.333 -4.9% downside
Franking for last dividend paid out: 96%
OTHER COMPANIES IN THE SAME SECTOR
SLA . CAJ . GXL . HSO . MPL . MVF . NHF . HLS . RHC . SHL . VRT . M7T . HLA . PSQ . SIL . PKS . ONT . DOC . NVL . AHX . ALC . ACL .
FNARENA'S MARKET CONSENSUS FORECASTS
EBO: 1
Title FY20
Actual
FY21
Actual
FY22
Forecast
FY23
Forecast
EPS (cps) xxx 113.2 125.6 xxx
DPS (cps) xxx 46.0 90.0 xxx
EPS Growth xxx 12.5% 10.9% xxx
DPS Growth xxx 15.0% 95.7% xxx
PE Ratio xxx N/A 26.9 xxx
Dividend Yield xxx N/A 2.7% xxx
Div Pay Ratio(%) xxx 40.6% 71.7% xxx

Dividend yield today if purchased 3 years ago: 2.25%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

1.30

Estimated Dividend Growth
(Average Of Past Three Years)

 %

Amount Invested

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 09/09 - ex-div 38.8c (franking 96%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2021 FactSet UK Limited. All rights reserved
Title 201620172018201920202021
EPS Basic xxxxxxxxxxxxxxx113.2
DPS All xxxxxxxxxxxxxxx86.0
Sales/Revenue xxxxxxxxxxxxxxx9,202.9 M
Book Value Per Share xxxxxxxxxxxxxxx859.5
Net Operating Cash Flow xxxxxxxxxxxxxxx298.3 M
Net Profit Margin xxxxxxxxxxxxxxx2.01 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201620172018201920202021
Return on Capital Employed xxxxxxxxxxxxxxx13.59 %
Return on Invested Capital xxxxxxxxxxxxxxx9.80 %
Return on Assets xxxxxxxxxxxxxxx4.82 %
Return on Equity xxxxxxxxxxxxxxx13.59 %
Return on Total Capital xxxxxxxxxxxxxxx13.68 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx96.2 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

This is work in progress. Bear with us. It'll be amazing.

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.4

No. Of Recommendations

5
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Citi

xx/xx/xxxx

3

xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgans

xx/xx/xxxx

3

xxxxxxxxx xx xxxx xxxx xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Macquarie

19/08/2021

1

Upgrade to Outperform from Neutral

-

-

Macquarie notes solid FY21 results, which reflected continued momentum in community pharmacy, in turn supporting earnings growth in the short to medium term.

Management provided no specific guidance but expects earnings growth in FY22, with risk caveats related to the pandemic. The broker finds earnings momentum quality supportive and upgrades to Outperform from Neutral. Target rises to NZ$35.49 from NZ$33.70.

FORECAST
Macquarie forecasts a full year FY22 dividend of 99.40 cents and EPS of 128.90 cents.
Macquarie forecasts a full year FY23 dividend of 107.60 cents and EPS of 139.50 cents.

UBS

xx/xx/xxxx

1

xxx

-

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Credit Suisse

xx/xx/xxxx

3

xxxxxxxxxx xx xxxxxxx xxxx xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

EBO STOCK CHART